We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

GMAB

Market closed
Access this stock data via API
Subscribe
Genmab A/S
0
0
0%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 715M 6.4B 5.5B 5.4B
Cost of revenue 42M 337M 273M 190M
Gross profit 673M 6.1B 5.3B 5.2B
Operating expense
Research & development 359M 2.7B 2.3B 2.5B
Selling general and admin 126M 1.2B 865M 894M
Other operating expenses
Operating income 188M 2.2B 2.1B 1.8B
Non operating interest income
Income 33M 224M 162M 292M
Expense 5M 54M 18M 19M
Other income expense 28M 1.2B -544M 38M
Pretax income 244M 3.6B 1.7B 2.1B
Tax provision 49M -243M 453M 719M
Net income 195M 3.8B 1.3B 1.4B
Basic EPS 3.1 19.9 21.9
Diluted EPS 3.1 19.8 21.7
Basic average shares 419.2M 417.6M 423.9M
Diluted average shares 420.6M 420.4M 426.8M
EBITDA 237M 2.5B 2.4B 2.3B
Net income from continuing op. 244M 3.6B 1.7B 3.6B
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed (non-working day)
Main market opens in 2 days 3 hours 31 minutes

05:28
00:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:00
All times are displayed in the Europe/Copenhagen timezone (CEST, UTC+02:00).